There are two types of TSH receptor antibodies (TRAb); thyroid stimulating antibody (TSAb) and TSH-stimulation blocking antibody (TSBAb). TSAb causes Graves’ hyperthyroidism. TSBAb causes hypothyroidism. Both TSAb and TSBAb block TSH-binding to thyroid cells as TSH receptor antibodies (TRAb). TSBAb-positive patients with hypothyroidism and Graves’ patients with hyperthyroidism may have both TSBAb and TSAb. We studied TSBAb and TSAb in 43 TSBAb-positive patients with hypothyroidism and in 55 untreated Graves' patients with hyperthyroidism. TSBAb-activities were expressed as percentage inhibition of bovine (b) TSH-stimulated cAMP production by test IgG. Two formulas were used to calculate TSBAb-activities; TSBAb-A (%) = [1 - (c - b)/(a - b)] × 100 and TSBAb-B (%) = [1 - (c - d)/(a - b)] × 100, where a: cAMP generated in the presence of normal IgG and bTSH, b: cAMP generated in the presence of normal IgG, c: cAMP generated in the presence of test IgG and bTSH, and d: cAMP generated in the presence of test IgG. TSAb (%) = [d/b] × 100. All of the 43 TSBAb-positive patients with hypothyroidism had strongly positive TSBAb-A and -B. Some of them had weakly positive TSAb (< 240 %). All 55 untreated Graves’ patients had positive TSAb (205 - 2509 %). Some of them had both TSAb and TSBAb. TSBAb-positive patients with hypothyroidism had a limited distribution of TSBAb- and TSAb-activities (TSBAb-A + 75 - + 103 %, TSBAb-B + 87 - + 106 %, TSAb 92 - 240 %), but Graves' patients with hyperthyroidsim had a wide distribution of TSAb- and TSBAb-activities (TSAb 205 - 2509 %, TSBAb-A - 158 - + 43 %, TSBAb-B - 14 - + 164 %). TSBAb-A ignores TSAb activity in serum, and might give low TSBAb activity. However, TSBAb-A clearly differentiates TSBAb-positive patients with hypothyroidism from Graves’ patients with hyperthyroidism; thus, we favor TSBAb-A over TSBAb-B. Some of TSBAb-positive patients with hypothyroidism and Graves' patients with hyperthyroidism have both TSBAb and TSAb.
Key words:
TSBAb: TSH-Stimulation Blocking Antibody - TSAb: Thyroid Stimulating Antibody - TRAb: TSH-Receptor Antibody - Graves' Disease - TSBAb-Positive Hypothyroidism - TRAb Disease
References:
1
Takasu N, Yamada T, Takasu M, Komiya I, Nagasawa Y, Asawa T, Shinoda T, Aizawa T, Koizumi Y.
Disappearance of thyrotropin-blocking antibodies and spontaneous recovery from hypothyroidism in autoimmune thyroiditis.
N Engl J Med.
1992;
326
513-518
2
Ludgate M E, Vassart G.
The thyrotropin receptor as a model to illustrate receptor and receptor antibody diseases.
Baillières Clin Endocrinol Metab.
1995;
9
95-113
3
Endo K, Kasagi K, Konishi J, Ikekubo K, Okuno T, Takeda Y, Mori T, Torizuka K.
Detection and properties of TSH-binding inhibitor immunoglobulins in patients with Graves’ disease and Hashimoto’s thyroiditis.
J Clin Endocrinol Metab.
1978;
46
734-739
4 Rees Smith & Halls R. Measurement of thyrotropin receptor antibodies. Methods Enzymol 1981 74 Pt C: 405-420
5
Kasagi K, Konishi J, Iida Y, Ikekubo K, Mori T, Kuma K, Torizuka K.
A new in vitro assay for human thyroid stimulator using cultured thyroid cells: effect of sodium chloride on adenosine 3’,5’-monophosphate increase.
J Clin Endocrinol Metab.
1982;
54
108-114
6
Davies T F, Platzer M, Schwartz A, Friedman E.
Functionality of thyroid-stimulating antibodies assessed by cryopreserved human thyroid cell bioassay.
J Clin Endocrinol Metab.
1983;
57
1021-1027
7
Rapoport B, Greenspan F S, Filetti S, Pepitone M.
Clinical experience with a human thyroid cell bioassay for thyroid-stimulating immunoglobulin.
J Clin Endocrinol Metab.
1984;
58
332-338
8
Ludgate M, Perret J, Parmentier M, Gerard C, Libert F, Dumont J E, Vassart G.
Use of the recombinant human thyrotropin receptor (TSH-R) expressed in mammalian cell lines to assay TSH-R autoantibodies.
Mol Cell Endocrinol.
1990;
73
R13-18
9
Takasu N, Mori T, Koizumi Y, Takeuchi S, Yamada T.
Transient neonatal hypothyroidism due to maternal immunoglobulins that inhibit thyrotropin-binding and post-receptor processes.
J Clin Endocrinol Metab.
1984;
59
142-146
10
Takasu N, Yamada T, Katakura M, Yamauchi K, Shimizu Y, Ishizuki Y.
Evidence for thyrotropin (TSH)-blocking activity in goitrous Hashimoto’s thyroiditis with assays measuring inhibition of TSH receptor binding and TSH-stimulated thyroid adenosine 3’,5’-monophosphate responses/cell growth by immunoglobulins.
J Clin Endocrinol Metab.
1987;
64
239-245
11
Takasu N, Yamada T, Sato A, Nakagawa M, Komiya I, Nagasawa Y, Asawa T.
Graves’ disease following hypothyroidism due to Hashimoto’s disease: studies of eight cases.
Clin Endocrinol (Oxf).
1990;
33
687-698
12
Takasu N, Oshiro C, Akamine H, Komiya I, Nagata A, Sato Y, Yoshimura H, Ito K.
Thyroid-stimulating antibody and TSH-binding inhibitor immunoglobulin in 277 Graves’ patients and in 686 normal subjects.
J Endocrinol Invest.
1997;
20
452-461
13
Macchia E, Concetti R, Carone G, Borgoni F, Fenzi G F, Pinchera A.
Demonstration of blocking immunoglobulin G, having a heterogeneous behavior, in sera of patients with Graves’ disease: possible coexistence of different autoantibodies directed to the TSH receptor.
Clin Endocrinol (Oxf).
1988;
28
147-156
14
Miyauchi A, Amino N, Tamaki H, Kuma K.
Coexistence of thyroid stimulating and thyroid blocking antibodies in a patient with Graves’ disease who had transient hypothyroidism.
Amer J Med.
1988;
85
418-420
15
Tamai H, Kasagi K, Takaichi Y, Takamatsu J, Komaki G, Matsubayashi S, Konishi J, Kuma K, Kumagai L, Nagataki S.
Development of spontaneous hypothyroidism in patients with Graves’ disease treated with antithyroidal drugs: clinical immunological and histological findings in 26 patients.
J Clin Endocrinol Metab.
1989;
69
49-53
16
Morita T, Tamai H, Oshima A, Mukuta T, Fukata S, Kuma K, Kumagai L F, Nagataki S.
The occurrence of thyrotropin binding inhibitory immunoglobulin and thyroid stimulating antibodies in patients with silent thyroiditis.
J Clin Endocrinol Metab.
1990;
71
1051-1055
17
Kasagi K, Hidaka A, Endo K, Miyamoto S, Takeuchi R, Misaki T, Sakahara H, Konishi J.
Fluctuating thyroid function depending on the balance between stimulating and blocking types of TSH receptor antibodies: a case report.
Thyroid.
1993;
3
315-318
18
Ogura M, Kouki T, Inui I, Hachiya T, Ochi Y, Kajita Y.
Demonstration of thyroactive smaller components released from TSAb-IgG by protease digestion.
Thyroid.
1995;
5
449-454
19
Kouki T, Inui T, Yamashiro K, Hachiya T, Ochi Y, Kajita Y, Takasu N, Sato Y, Nagata A.
Demonstration of fragments with thyroid stimulating activity from thyroid stimulation blocking antibodies-IgG molecules by papain digestion.
Clin Endocrinol (Oxf).
1997;
47
693-698
20
Konishi J, Iida Y, Endo K, Misaki T, Nohara Y, Matuura N, Mori T, Torizuka K.
Inhibition of thyrotropin-induced adenine 3’5’-monophosphate increase by immunoglobulin from patients with primary myxedema.
J Clin Endocrinol Metab.
1983;
57
544-549
21
Inomata H, Sasaki N, Tamaru K, Ushiku H, Nimi H, Nakajima H.
Relationship between potency of blocking type thyrotropin-binding inhibitor immunoglobulin in three women with primary myedema and thyroid function of their neonates.
Endocrinol Jap.
1986;
33
353-359
22
Yokoyama N, Izumi M, Katamine S, Nagataki S.
Heterogeneity of Graves’ immunoglobulin G; comparison of thyrotropin receptor antibody in serum and in culture supernatant of lymphocytes transformed by Epstein-Barr virus infection.
J Clin Endocrinol Metab.
1987;
64
215-218
23
Matsui I, Sakata S, Ogawa T, Takuno H, Sarui H, Komaki T, Manshouri T, Atassi Z.
Biological activities of rat antisera raised against synthetic peptide of human thyrotropin receptor.
Endocr J.
1993;
40
607-612
24
Hidaka Y, Guimaraes V, Soliman M, Yanagawa T, Okamoto Y, Quintans J, DeGroot L J.
Production of thyroid-stimulating antibodies in mice by immunization with T-cell epitopes of human thyrotropin receptor.
Endocrinology.
1995;
136
1642-1647
25
Takeda K, Takamatsu J, Kasagi K, Sakane S, Ikegami Y, Isotani H, Majima T, Majima M, Kitaoka H, Iida Y, Ikekubo K, Konishi J, Mozai T.
Development of hyperthyroidism following primary hypothyroidism: a case report with changes in thyroid-related antibodies.
Clin Endocrinol (Oxf).
1988;
28
341-344
26
Michelangeli Y P, Poon C, Topliss D J, Colman P G.
Specific effect of radioiodine treatment on TSAb and TBAb levels in patients with Graves’ disease.
Thyroid.
1995;
5
171-176
N. Takasu,M.D.
Department of Internal Medicine University of the Ryukyus
Uehara 207, Nishihara, Okinawa Japan 903-0215
Fax: Fax:+ 81-098-895-1415